Long-Term Outcomes of Femoral Derotation Osteotomy for Individuals With Cerebral Palsy
Completed
Conditions studied: Cerebral Palsy, Femoral Derotation Osteotomy, Outcomes
In brief
Excessive anteversion is commonly observed in the cerebral palsy (CP) population. This can be treated by an orthopedic surgery, called femoral derotation osteotomy (FDO), to de-rotate the femur. It is a vital aspect of patient care to understand if the effects of an FDO are maintained long-term. The results of this study will have direct clinical impact by equipping providers with the necessary information to counsel families by providing families the information needed to make the most informed decision possible about this aspect of their child's healthcare.
Key facts
- Study ID
- NCT03444116
- Run by
- Gillette Children's Specialty Healthcare
- People needed
- 62
- Starts
- 2017-09-12
- Expected to finish
- 2019-11-15
- Last updated by the study team
- 2021-02-10
Who can join
Age: 25 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with bilateral CP (i.e., hemiplegics excluded)
- Minimum age of 25 years presently
- Had a preoperative gait analysis
- Underwent only 1 external, proximal FDO per side
- Minimum 5 years since an FDO
- FDO implants have been removed
- No prior pelvic osteotomy
- Able to speak and read English
- Not pregnant
- Control group (-FDO):
- Same as cases, except no FDO
- Matched to cases at baseline (using a matching algorithm)
You may not qualify if…
- none
Where it is running
- Gillette Children's Specialty Healthcare — Saint Paul, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.